Company intelligence / Profile preview

Habit

Ownership: Private
Development stage: Commercial

Overview

Habit was a pioneer in using at-home diagnostics combined with digital platforms to deliver personalized nutritional recommendations based on individual biology. The company did not develop therapeutics but instead focused on improving health outcomes through tailored diet plans. Clinical results as understood were related to user engagement and improved dietary habits rather than clinical trials of drugs.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Non-pharmacological therapyDiagnosticsDigital health platform
Industry: Metabolite Diagnostics

Partnerships

Campbell Soup Company

Beyond the preview

Go deeper on Habit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Habit.

Explore the full profile